Reduction in subthalamic 8–35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease

898 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

High-Frequency Stimulation of the Subthalamic Nucleus Suppresses Oscillatory β Activity in Patients with Parkinson's Disease in Parallel with Improvement in Motor Performance (2008, neutral): “Our findings give correlative evidence that HFS may act by reducing oscillatory STN LFP activity in PD patients, thereby mirroring the effect of levodopa on this activity (Brown et al., 2001; Priori et al., 2004; Kühn et al., 2006).”
Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. (2006, result): “Our findings are also consistent with the recently reported findings that levodopa-induced reduction in subthalamic LFP power in the 8-to 35-Hz band as recorded postoperatively from DBS electrodes correlates with the simultaneously observed clinical improvement in PD patients (Kuhn et al. 2006).”
Dichotomous frequency-dependent phase synchrony in the sensorimotor network characterizes simplistic movement (2024, background): “This is consistent with literature suggesting that beta rhythms are critical to synchronize sensorimotor neural populations for initiating normal movement 33,34 and implicated in disorders of movement initiation such as Parkinson’s disease 35,36 .”